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Historically, persistence phenomenon was first described in
1944 when J. W. Bigger discovered that in presence of peni-
cillin, a small proportion of bacteria named “persisters”, were
able to survive without acquiring antibiotic resistance [1].
Indeed, subcultures obtained from persisters and treated with
antibiotic were as sensitive as the pure culture grown in
absence of antibiotics. Bacterial persistence is commonly
defined as the ability of a specific subpopulation of bacteria to
grow in presence of antibiotic treatment or to escape from
innate and adaptive immunity by becoming “invisible”.
Additionally, persistence can also describe a viable but not
cultivable stage resulting in the prolonged colonization of the
host. Because of these diverse definitions, the term persistence
should be used carefully since it can be interpreted in different
ways.
Due to their obligate or facultative intracellular lifestyle,
bacteria such as Chlamydiales, Anaplasma and Bartonella
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immunity. Furthermore, obligate intracellular bacteria need
host resources for their own development as well as to ensure
their transmission to a new host. Therefore, intracellular
bacteria have developed diverse strategies in order to escape
host immunity and finally proliferate inside their host. Inter-
estingly, in adverse conditions in which proliferation is not
possible, some obligate intracellular bacteria have developed
mechanisms of persistence, allowing their survival, waiting for
more favourable conditions.
This review aimed to highlight the diversity of persistence
mechanisms used by different obligate intracellular bacteria
such as Chlamydiales, Anaplasma or Bartonella. Members of
the Chlamydiales order are known to form a persistent stage,
named aberrant bodies (ABs), or to interfere with the nuclear
factor-kappa B (NFkB), a protein complex known to play a
key role in regulating the immune response to infection. In
contrast, Anaplasma persistence can occur by antigenic vari-
ation of the major surface proteins (MSPs) or by the lack of
peptidoglycan (PG) layer or lipopolysaccharide (LPS). Finally,
Bartonella spp. have developed diverse mechanisms such as
harbouring a low-potency LPS, stimulation of interleukine-10
(IL-10) secretion or antigenic variation of their adhesins.Bartonella: persistence and immune escape of intracellular bacteria, Microbes
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lular Gram-negative bacteria that can cause widespread in-
fections in human and in animals. The order is divided
between the Chlamydiaceae, including two well-studied
human pathogens, Chlamydia trachomatis and Chlamydia
pneumoniae, and the Chlamydia-related bacteria grouping
nine described families up to date [2].
C. trachomatis represents the most common bacterial
sexually transmitted infection and leads to fallopian tubes
injuries and infertility in women. Nearly 130 million new
incident cases are reported each year [3]. Furthermore, this
bacterium is responsible for trachoma which remains the
world's leading infectious cause of blindness despite efforts to
eradicate the disease. C. pneumoniae is responsible for acute
respiratory diseases in human, including pneumonia and
bronchitis. An inflammatory disease, the reactive arthritis, is
also associated with C. trachomatis and to a lesser extent with
C. pneumoniae [4]. Chlamydia abortus causes abortion in
mammals and represents a zoonotic risk to pregnant women
resulting in adverse pregnancy outcomes [5]. Furthermore,
birds such as parrots or parakeets represent the main reservoir
of Chlamydia psittaci, the agent responsible for human and
avian psittacosis [6]. Chlamydia suis, an animal pathogen,
causes arthritis, conjunctivitis, pneumonia, reproductive dis-
orders and rhinitis in pigs [7]. Finally,Waddlia chondrophila, a
Chlamydia-related bacterium, is probably associated with
abortion in ruminants [8] and human miscarriages [9].2.2. BiologyAll chlamydial members share a typical biphasic life cycle
including two developmental stages: the infectious non-
dividing elementary bodies (EBs) [10] and the non-
infectious dividing reticulate bodies (RBs) [11]. The life
cycle starts with the entry of EBs into the host cells by
endocytosis or phagocytosis. Once inside the cells, EBs reside
in a vacuole called inclusion and are finally converted into
RBs. Ultimately, RBs redifferentiate into EBs which are
released by exocytosis or cell lysis in order to start a new life
cycle. In some stress conditions, the chlamydial bacteria
exhibit an alternative and persistent stage called ABs. The
stress stimuli removal allows the redifferentiation of ABs into
RBs, and subsequently into infectious EBs [12].2.3. Aberrant bodiesDiverse stimuli can induce ABs such as the addition of
b-lactam antibiotics [13], including penicillin (Fig. 1), star-
vation of iron or nutrients [14], treatment with interferon-
gamma (IFN-g) [15] or phosphomycin [16], as well as
coinfection of the host with herpes or other viruses [17,18].
ABs are characterized by an abnormal enlargement of the
bacteria that seems to be due to a continuous DNA replicationPlease cite this article in press as: Scherler A, et al., Chlamydiales, Anaplasma and
and Infection (2017), https://doi.org/10.1016/j.micinf.2017.11.002without division [19]. Indeed, when C. trachomatis is treated
with penicillin, each AB accumulates more than 16 chromo-
somal copies [20]. As mentioned earlier, the removal of stress
stimuli allows the bacteria to re-enter its normal life cycle. As
an example, C. trachomatis needs between 10 and 20 h to
recover its normal developmental cycle after penicillin
removal. Furthermore, ABs seem to re-differentiate by
budding process but do not produce initially normal sized RBs
[21]. It was also shown that C. psittaci infecting HeLa cells
could be maintained in a viable and persistent infection for
6e9 months with the presence of penicillin and antiserum.
When the antibiotics and the antibodies were removed, an
acute infectious resumed, characterized by recoverable infec-
tious EBs [22]. From these observations, ABs are considered
as a persistent stage and this feature might be conserved
among Chlamydiales as they have been described in W.
chondrophila, a Chlamydia-related bacterium [23]. In addi-
tion, ABs can be induced in absence of exogenous stress
stimuli as reported in untreated human endometrial cells
infected with W. chondrophila. Indeed, ABs were observed at
72 h post infection (hpi), 96 hpi and 120 hpi, probably in
response to nutrient starvation [23].
Furthermore, numerous studies have investigated how
stress-inducing treatments impact the expression of diverse
functional subsets of chlamydial genes compared to untreated
infected cells. The expression of some highly antigenic pro-
teins such as major outer membrane protein (MOMP) was
reduced in persistence induced by herpes simplex virus co-
infection [18] or by IFN-g treatment [24]. However, another
study has also reported an up-regulation of the ompA gene
encoding MOMP in C. pneumoniae-infected cells and treated
with IFN-g [25]. Real-Time RT-PCR on C. trachomatis
infected Hep-2 cells has identified increased expression of
heat-shock response genes ct604 and ct755 at 96 hpi in
response to IFN-g [26]. Interestingly, ct604 and ct755 were not
described as up-regulated genes in persistent C. trachomatis
infection in a study published earlier [27]. In this study, genes
implying tryptophan utilization, DNA repair and recombina-
tion, phospholipid biosynthesis, protein translation, and gen-
eral stress genes were shown to be up-regulated and genes
involved in proteolysis, peptide transport, and cell division
were down-regulated during persistence [27]. From these re-
sults, no subset of genes can be clearly defined as a marker of
persistence. The differences in up/down regulated chlamydial
gene sets may represent the key event to understand the
occurrence of ABs but the mechanism behind their formation
remains unclear [19]. These in vitro models provide evidence
for abnormal chlamydial growth under stress conditions but
they do not bring any clue regarding the occurrence of ABs as
an in vivo persistence mechanism in infected patients.2.4. Clinical importanceAlthough chlamydial persistence in vitro has been well
documented, only few studies have demonstrated in vivo
persistence. By using transmission electron microscopy, Pos-
pischil et al. have detected ABs in the intestinal enterocytes ofBartonella: persistence and immune escape of intracellular bacteria, Microbes
Fig. 1. Penicillin treatment induces aberrant bodies in different cell lines infected with distinct Chlamydiales members at 24 h post infection (hpi): (A).
C. trachomatis infected McCoy cells treated with 0.6 mg/ml penicillin and stained with anti-LPS antibodies (green) (B). Vero cells infected with W. chondrophila,
treated with penicillin at 1,000 mg/ml and labelled with anti-Waddlia antibodies (green) (C). Penicillin treatment at 500 mg/ml in Vero cells infected with Estrella
lausannensis labelled with anti-OMP antibodies (green). In all conditions, drugs were added at 2 hpi and infected cells were fixed with methanol at 24 hpi. Fixed
cells were labelled with DAPI (blue), concanavalin A (red, panels A and B) or specific antibodies against E. lausannensis (panel C). Scale bars represent 5 mm.
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[28]. Furthermore, aberrant bacterial forms were observed by
electron microscopy in the female genital tract from non-
treated C. trachomatis infected patients [29]. More recently,
whole-genome sequencing was performed on strains obtained
from patients with long-term persistent C. trachomatis infec-
tion and data showed remarkable genome stability over a long
period of time. According to these results, persistence is thus
apparently not related to pathogen mutational event [30].
From these in vivo observations, persistent stage is thought
to play an important role in the initiation of persistent in-
fections by Chlamydiales, which leads to serious complica-
tions, including pelvic pain and ectopic pregnancy.
Nevertheless, only few in vivo cases were reported and
therefore their consequences and occurrence rate remain un-
defined. Repeated infections are also difficult to differentiate
from long-term persistence. Therefore, the link between
persistent forms observed in vitro and the in vivo survival
mechanisms should be clarified in the future.2.5. Other mechanisms of persistenceThe formation of ABs might be one possible cause of
chlamydial persistence but it might also be caused by others
mechanisms. For example, C. trachomatis infections can
persist asymptomatically for months before being spontane-
ously cleared by the host, suggesting a likely escape from the
host immunity. A possible strategy might involve the bacterial
interference with the inflammatory transcription factor, NFkB,
a regulator of immune responses to infection. Indeed, Chla-
mydia pecorum, an animal pathogen, was shown to induce
significant NFkB activation at 24 hpi in human cells, sug-
gesting its role in early inflammatory response. In contrast, C.
trachomatis and C. suis exhibited less NFkB activation [31].
To escape from host-innate immunity, Chlamydia has also
developed a mechanism to reduce the recognition of PAMPs
(pathogen-associated molecular patterns) by guarantying the
stability of the pathogen-containing vacuole during the in-
fectious intracellular stage. Therefore, inclusions are stabilized
by a network of F-actin and intermediate filaments avoidingPlease cite this article in press as: Scherler A, et al., Chlamydiales, Anaplasma and
and Infection (2017), https://doi.org/10.1016/j.micinf.2017.11.002thus the efflux of bacterial content into the host and its sub-
sequent detection [32]. Furthermore, a truncated LPS with low
endotoxic activity is localized on the chlamydial outer mem-
brane and helps to reduce the recognition of Chlamydiae [33].
Finally, cytokines production elicited during productive
infection and persistent infection varies according to the
infected cells, as well as the immune status of the individual
[34].
3. Anaplasma3.1. PathogenicityAnother obligate intracellular genus, Anaplasma, from the
order Rickettsiales, is composed of ixodid tick-transmitted
Gram-negative bacteria including two notable species: Ana-
plasma marginale and Anaplasma phagocytophilum. Ana-
plasma spp. can be transmitted by biting flies or by blood-
contaminated fomites including needles, tattooing in-
struments or nose tongs [35].
Present worldwide and exclusively in ruminants' infection,
A. marginale replicates in erythrocytes leading to bovine
anaplasmosis principally in cattle and to a less extent in sheep,
goats, buffalo, or in some wild ruminants [35]. Following
transmission, an acute infection occurs with a peak between 3
and 7 weeks post-infection due to the ascending bacteraemia
resulting in symptoms such as anaemia, fever, weight loss,
dehydration, lower milk production, constipation, abortion in
pregnant animals and finally death [36].
Contrary to A. marginale, A. phagocytophilum can infect
human as well as animals including carnivores, ruminants,
rodents, birds and reptiles [37]. Furthermore, A. phag-
ocytophilum does not replicate in erythrocytes but within the
vacuoles of neutrophils and leads to human granulocytic
anaplasmosis. In infected humans, clinical manifestations vary
from asymptomatic to severe disease with fever, malaise,
headache, myalgia, anaemia, nausea, thrombocytopenia or
leukopenia. In a small number of cases (<3%), patients
experiment acute anaplasmosis due to toxic shock-like syn-
drome or acute respiratory distress syndrome that can lead toBartonella: persistence and immune escape of intracellular bacteria, Microbes
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is the causative agent of tick borne fever, which affects prin-
cipally small ruminants such as sheep and to a less extent,
goats, cattle, horses, dogs and cats (reviewed in Ref. [39]). The
main symptoms of tick borne fever in sheep include a high
fever and a leukopenia implicating both granulocytes and
lymphocytes [40].
Finally, four other species are pathogenic towards animals:
Anaplasma bovis, Anaplasma centrale, Anaplasma ovis and
Anaplasma platys [39].3.2. BiologyAs mentioned above, Anaplasma spp. are transmitted by
ixodid ticks which feed on a wide variety of vertebrate hosts in
which bacteria can potentially establish persistent infections.
During blood meal on an infected host, Anaplasma spp. enter
the tick midgut epithelium. After initial replication in tick gut
cells, bacteria reach the tick salivary glands where a second
replication occurs, and then migrate to the saliva allowing
Anaplasma transmission to the next vertebrate host [41].
Interestingly, the Anaplasma developmental cycle exhibits two
distinct forms. The first named “reticulate cell” represents the
non-infectious replicative form and then it changes to the in-
fectious “dense-cored cell” containing a dense nucleoid and
surviving outside the host cells. Both morphological forms
replicate by binary fission [42].3.3. In vitro strategies developed by Anaplasma spp.Anaplasma spp. have developed numerous strategies to
persistently infect ticks and hosts which subsequently become
reservoirs of infection allowing the transmission of the path-
ogen. The antigenic variation through the major surface pro-
teins (MSPs) appears to be one of the major mechanisms to
establish persistent infections. MSPs, such as MSP1, MSP2
(P44), MSP3 or MSP4, are immunodominant outer membrane
proteins present in the Anaplasmataceae family and have been
broadly studied especially in A. marginale and A. phag-
ocytophilum. In both bacteria, a recombinant mechanism is
used to generate new antigenic variants of their surface pro-
teins in order to evade host immune response. For example,
A. marginale possesses pseudogenes for two gene families,
msp2 and msp3, which can be recombined into the functional
expression site to produce new antigenic variants during
bacterial proliferation [43]. Furthermore, a second level of
variation occurs when short segments of pseudogenes are
recombined into the expression site by gene conversion
allowing the generation of a large collection of outer mem-
brane protein variants [44]. Concerning A. phagocytophilum,
comparable combinatorial mechanisms happen with
MSP2(P44), a MSP2 homologue of A. marginale, in order to
generate a broad diversity of variants [45]. To summarize,
immunodominant surface proteins MSP2 and MSP3 in
A. marginale and MSP2(P44) in A. phagocytophilum are un-
dergoing antigenic variations to allow bacterial escape from
host immune responses, which leads to persistent infection.Please cite this article in press as: Scherler A, et al., Chlamydiales, Anaplasma and
and Infection (2017), https://doi.org/10.1016/j.micinf.2017.11.002Additionally, members of Anaplasma genus show no evi-
dence of peptidoglycan (PG) layer or lipopolysaccharide
(LPS) biosynthesis [46]. LPS or PG are normally recognized
as PAMPs by pattern recognition receptors such as Toll-like
and NOD receptors, expressed by macrophages or neutro-
phils, which lead to innate immune responses in order to
eliminate the pathogens. Genome sequencing of A. phag-
ocytophilum confirmed the absence of genes coding for the
biosynthesis of lipid A and nearly all genes required for PG
biosynthesis [47]. Consequently, the absence of PG and LPS
allows Anaplasma to infect its host cell without activating the
innate immune response and thus enables the bacterial
persistence in the host.3.4. Persistent Anaplasma infectionsVarious studies have established in vivo persistence con-
firming the key role of the different mechanisms previously
described in vitro. For example, in A. marginale infected
cattle, the acute infection is characterized by high bacteraemia
reaching between 108 and 109 bacteria/ml of blood. However,
the acute infection is not completely cleared in surviving an-
imals and cycles of bacteraemia varying between 102 and 107
bacteria/ml of blood continue to occur every 6e8 weeks
throughout lifelong persistent infection [48]. Additionally,
numerous studies have reported persistent infections with
A. phagocytophilum in various vertebrate hosts such as sheep,
dogs, lambs, cattle or horses. For example, in sheep infected
experimentally with A. phagocytophilum, bacterial DNA was
still detectable within peripheral blood almost one year after
the beginning of the infection, indicating a long-term DNA
persistence. However, no reported case of persistent infection
with A. phagocytophilum has been reported in humans up to
now and no clinical evidences have confirmed the potential
impact of persistent infection on the onset of chronic illness
[38]. In contrast to A. phagocytophilum, A. platys, which is
known to be implicated in persistent infections in dogs, was
repetitively detected by PCR testing of blood samples taken
from two family members and their dog confirming its intra-
vascular persistence in human [49].
To conclude, numerous studies have confirmed the persis-
tence of Anaplasma spp. inside mammalian hosts which are
therefore considered as reservoirs of infection. Indeed,
persistently infected species act as a source of infections for
the tick vectors and thus impact directly the epidemiology and
the transmission of anaplasmosis. Nevertheless, persistent in-
fections are not always identified as such due to the low
concentrations of bacteria present in blood samples and to the
inaccuracy of techniques previously used for the detection.
4. Bartonella4.1. PathogenicityThe Bartonella genus is composed of Gram-negative
facultative intracellular bacteria which have developed
different strategies to persist in intraerythrocytic niche.Bartonella: persistence and immune escape of intracellular bacteria, Microbes
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human-restricted pathogen causing Carrion's disease which
can reach up to 88% of mortality in untreated patients during
the acute infection [50]. The disease is characterized by two
distinct phases beginning with the Oroya fever, which symp-
toms are fever, haemolytic anaemia, headache or muscle pains.
A subsequent and chronic stage, called verruga peruana, oc-
curs, causing distinctive red-to-purple vascular lesions of the
skin [51]. Another member of this genus, Bartonella quintana,
infects humans and causes trench fever characterized by peaks
of fever, rash, bone pain and headache with only limited
morbidity. Furthermore, B. quintana infection can induce a
persistent bacteraemia [52]. Finally, Bartonella henselae
causes cat scratch disease with mild symptoms such as fever,
chills, malaise or papule at the inoculation site [51]. Infection
by B. henselae is usually associated with low morbidity but, in
some patients, more serious manifestations can occur such as
neuroretinitis, encephalitis or endocarditis [53].
To summarize, human bartonellosis are mainly caused by
the three species described above but the Bartonella genus
contains as many as 45 species, among which 13 have been
implicated in human diseases. These include Bartonella
clarridgeiae, Bartonella elizabethae and Bartonella rochali-
mae, which were isolated from various vertebrate reservoirs
such as cats, rats or foxes [54].4.2. BiologyBartonellosis vectors are sandfly species of the genera
Lutzomyia for B. bacilliformis [55] and human body lice for
B. quintana. For both bacteria, humans are considered to
represent the main reservoir since no animal reservoir has been
clearly established. However, natural or experimental inocu-
lation of B. quintana in rhesus macaques lead to infection
suggesting that Bartonella spp. may also use few other pri-
mates as reservoirs [56,57]. In contrast, the main host of
B. henselae is domestic cats, which then transmit the bacte-
rium to humans via cat fleas, animal scratches or bites.
Following Bartonella transmission, the pathogen resides in
a still debating primary niche which seems to be required for
the completion of the developmental life cycle. The bacteria
are then transported to the vascular endothelium where bac-
terial persistence can occur. Later on, the bacteria are
disseminated into the bloodstream where they invade eryth-
rocytes, potentially allowing the reinfection of the primary
niche. Interestingly, they can persist in the intraerythrocytic
niche leading to specific asymptomatic bacteraemia [58].4.3. In vitro persistenceVarious strategies have been developed by the Bartonella
spp. to establish persistent infection inside the host by evading
innate and adaptive immune responses. One of these strategies
consists in harbouring a low-potency LPS. Indeed, B. henselae
was shown to create a deep-rough-type LPS depleted of O-
chain. In addition, the pathogen harbours some unusual
structural characteristics such as a long-chain fatty acid, whichPlease cite this article in press as: Scherler A, et al., Chlamydiales, Anaplasma and
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intracellular infections like Chlamydia. Interestingly, Toll-like
receptor 4 signalling was activated at least 1,000-fold less by
the B. henselae LPS compared with that of Salmonella [59].
According to these results, the modified form of LPS found in
Bartonella spp. seems to contribute largely to the bacterial
establishment and persistence.
Furthermore, members of the Bartonella genus can stimu-
late the secretion of IL-10, a key cytokine regulating immu-
nity. Indeed, IL-10 suppresses the activity of various immune
cells such as dendritic cells, macrophages/monocytes and T
helper cells, which leads to an interference with the host im-
mune responses. In IL-10 knockout mice, Bartonella birtlesii,
a bacterium isolated from field mouse, could not establish a
stable infection [60]. These results confirm the important role
of IL-10 to promote persistence establishment of Bartonella
infection. In addition, the Trw type IV secretion system
(T4SS) may be necessary to establish persistent bacteraemia in
erythrocytes as it displays extremely effective source of anti-
genic variability, which represents a crucial factor of eryth-
rocyte adhesion [61]. Interestingly, B. bacilliformis, which
does not likely cause intraerythrocytic persistent bacteraemia,
lacks a T4SS in contrary to B. quintana and B. henselae which
are able to persist in erythrocytes and possess two T4SS, Trw
system and VirB/VirD4 [62].
Numerous surface proteins can undergo phase or antigenic
variation as demonstrated for two adhesins, the variably
expressed OMP (Vomp) [56] and the Bartonella adhesin A
(BadA) [63]. Using a macaque model of B. quintana infection,
phase variation of Vomp was shown to be mediated by deletion
of one or more vomp genes during persistent bloodstream
infection [56]. This antigenic variation allows the bacteria to
subvert the host immune response and then persist in the
erythrocytes.
To summarize, intraerythrocytic persistent bacteraemia
might occur in almost all Bartonella spp. as confirmed for
B. quintana and B. henselae in host infection model such as
rhesus macaque or cats. Indeed, the persistence in erythrocytes
allows the escape from host's immune system as well as the
continuous transmission by arthropod vectors. Nevertheless,
intraerythrocytic persistence has never been reported in
B. bacilliformis which is probably the only exception among
Bartonella genus that can trigger massive haemolysis of the
infected human erythrocytes [64].4.4. In vivo persistenceSome in vivo persistence cases were reported in host res-
ervoirs such as human, cats or dogs. During a three-year
period, B. henselae was isolated from the blood culture of a
single cat on four occasions. B. clarridgeiae, another cat
scratch disease agent, could be isolated from another cat on
two distinct occasions. These observations suggest that a
persistent infection is present inside the reservoir. Further-
more, asymptomatic persistent infection with Bartonella vin-
sonii subsp. berkhoffii, an emerging pathogen, was also
described in a healthy dog along a period of 16 months [65]. InBartonella: persistence and immune escape of intracellular bacteria, Microbes
Table 1
Summary of persistence mechanisms present in Chlamydiales, Anaplasma and Bartonella spp.
Chlamydiales Anaplasma Bartonella
Abnormal morphology Enlarged aberrant bodies Absent Absent
Stimuli b-lactam antibiotics [13] / /
Iron or nutrients deprivation [14]
Interferon-g [15]
Phosphomycin [16]
In vitro evidences Presence of aberrant bodies induced
by different stimuli in various cell
lines
/ /
In vivo evidences Aberrant bodies in intestinal
enterocytes of pig with C. suis [28]
/ /
Aberrant bodies in female genital
tract [29]
Modulation of host immunity Interference with NF-kB [31] / Stimulation of IL-10 secretion [60]
Trw type IV secretion system [61,62]
Strutural modification Stabilization of pathogen-containing
vacuoles [32]
Antigenic variation via major surface
proteins [43e45]
Antigenic variation via adhesins
[56,63]
Truncated LPS [33] Absence of PG and of LPS [46] Low-potency LPS [59]
Implications of persistence Considered to be involved in serious
complications; pelvic pain and
ectopic pregnancy
Transmission to tick vectors Transmission to insect vectors
6 A. Scherler et al. / Microbes and Infection xx (2017) 1e8another study, cats experimentally infected with B. henselae
and/or B. clarridgeiae showed persistent bacteraemia for
almost 450 days. Furthermore, clinical symptoms were mini-
mal or even absent although Bartonella DNA was amplified
from different organs such as the liver, the brain or the kidney
[66]. Bartonella persistence has been also documented in 5
homeless patients infected with B. quintana for at least several
weeks as demonstrated by positive blood cultures [67].
Furthermore, clinical manifestations of persistent B. henselae
infections can occur in the form of bacillary angiomatosis and
bacillary peliosis in immunocompromised patients [61].
Taken all together, these results confirm that persistent
bacteraemia can be detected in the blood of cats, dogs and
human or as a vascular and proliferative form on the skin.
However, the maximal duration of persistence in reservoirs or
hosts is still unknown due to the difficulty to isolate Bartonella
species and to measure low bacteraemia.
5. Conclusions
As summarized in the Table 1, obligate or facultative
intracellular bacteria have developed a variety of mechanisms
in order to persist inside their hosts allowing thus access to
their resources. Among the groups of bacteria reviewed above,
interference with the immune responses is shared by Chla-
mydiales and Bartonella spp. through NFkB modulation or the
stimulation of IL-10 expression, respectively. One common
feature shared between Anaplasma and Bartonella is the
absence of LPS or the presence of low-potency LPS allowing
the evasion from host immunity detection. Furthermore, no
evidence of PG layer is found in Anaplasma genus. Interest-
ingly, Chlamydiaceae are known to have PG only at the di-
vision septum, which lowers immunity responses from the
host [68]. In order to subvert the host immune responses,
antigenic variation occurs through MSPs in Anaplasma or viaPlease cite this article in press as: Scherler A, et al., Chlamydiales, Anaplasma and
and Infection (2017), https://doi.org/10.1016/j.micinf.2017.11.002surface proteins such as Vomp and BadA adhesins in Barto-
nella. Furthermore, the stabilization of chlamydial inclusions
and the presence of T4SS in Bartonella can be mentioned as
mechanisms of persistence. Finally, typical forms of persis-
tence, such as aberrant bodies, are not found in Anaplasma or
Bartonella spp. which indicates that ABs are presumably
specific to Chlamydia. However, they also result in the
maintenance of low bacteraemia and escape from host im-
mune system.
To conclude, different essential mechanisms of persistence
have been developed by intracellular bacteria in order to
persist and then to be efficiently transmitted to new hosts.
Indeed, in case of over-stimulation of immune system by
bacteria, host immune responses will kill the pathogen and
cause disease with noticeable symptoms such as fever or
headache. On the contrary, if the host does not present any
symptoms, his behaviour will remain unchanged and the
bacterial transmission will continue. For example, if the
infection with C. trachomatis caused severe symptoms, the
host would not have sexual relations and then the bacterial
transmission would decrease significantly. Similarly, persistent
bacteraemia with low or absent symptoms in human and ani-
mals directly impacts the transmission of pathogens to other
accidental host reservoirs like human.
It is important to note that the diversity of persistence
strategies as well as their precise mechanisms remain unclear
and should be investigated in the future. Due to the low
number of pathogens and the asymptomatic manifestations,
in vivo bacterial persistence is not always detected in human
or in animals. Thus, future improvements of the diagnostic
techniques will allow the detection of persistent infection
despite the very low quantity of bacterial DNA, and thus lead
to an improvement of our knowledge on these persistence
mechanisms. Additionally, a better comprehension of bacterial
persistence will improve the treatments of infected human orBartonella: persistence and immune escape of intracellular bacteria, Microbes
7A. Scherler et al. / Microbes and Infection xx (2017) 1e8animals. Furthermore, systematic screening for pathogens
known to persist should be encouraged in order to detect and
treat asymptomatic infected patients and thus lower the prev-
alence of these pathogens.
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